Department of Drug Metabolism and Pharmacokinetics (DMPK)
Novartis Institutes for Biomedical Research
Dr. Alexander James is affiliated to Department of Drug Metabolism and Pharmacokinetics (DMPK), Novartis Institutes for Biomedical Research. Dr. Alexander James is currently providing services as Professor. Dr. Alexander James has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Alexander James contributions have acclaimed recognition from honourable subject experts around the world. Dr. Alexander James is actively associated with different societies and academies. Dr. Alexander James academic career is decorated with several reputed awards and funding. Dr. Alexander James research interests include Department of Drug Metabolism and Pharmacokinetics (DMPK).
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma.